The strategic future of healthcare in India is intrinsically linked to the concept of precision medicine, and within this domain, radiopharmaceuticals are set to play a pivotal role. The advancements in targeted therapies, specifically those leveraging therapeutic radioisotopes, are moving the market beyond traditional broad-spectrum treatments. These novel agents, such as those labeled with...
Market Overview
The global cardiac biomarkers market size was valued at USD 19.21 billion in 2024 and is projected to grow from USD 21.94 billion in 2025 to reach USD 63.46 billion in 2033, growing at a CAGR of 14.2% during the forecast period (2025–2033).
The global Cardiac Biomarkers market continues to...